BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,895 | -64.8% | 22,488 | -7.2% | 0.00% | – |
Q2 2023 | $161,458 | -64.5% | 24,243 | -0.4% | 0.00% | -100.0% |
Q1 2023 | $454,222 | -14.3% | 24,342 | -1.3% | 0.00% | 0.0% |
Q4 2022 | $529,804 | +84.0% | 24,665 | +1.1% | 0.00% | – |
Q3 2022 | $288,000 | -10.8% | 24,406 | -0.3% | 0.00% | -100.0% |
Q2 2022 | $323,000 | -36.3% | 24,475 | +0.9% | 0.00% | 0.0% |
Q1 2022 | $507,000 | -3.6% | 24,261 | -6.2% | 0.00% | 0.0% |
Q4 2021 | $526,000 | -31.2% | 25,851 | +2.6% | 0.00% | 0.0% |
Q3 2021 | $765,000 | +25.0% | 25,198 | +19.6% | 0.00% | 0.0% |
Q2 2021 | $612,000 | -26.4% | 21,071 | +9.3% | 0.00% | 0.0% |
Q1 2021 | $832,000 | -6.8% | 19,271 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $893,000 | +16.1% | 19,329 | +8.9% | 0.00% | 0.0% |
Q3 2020 | $769,000 | -9.1% | 17,742 | +11.2% | 0.00% | 0.0% |
Q2 2020 | $846,000 | +276.0% | 15,959 | +58.2% | 0.00% | – |
Q1 2020 | $225,000 | +65.4% | 10,085 | +8.7% | 0.00% | – |
Q4 2019 | $136,000 | +109.2% | 9,282 | 0.0% | 0.00% | – |
Q3 2019 | $65,000 | -36.3% | 9,282 | 0.0% | 0.00% | – |
Q2 2019 | $102,000 | – | 9,282 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |